Huiyin Lan

2.3k total citations · 1 hit paper
18 papers, 1.7k citations indexed

About

Huiyin Lan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Huiyin Lan has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Huiyin Lan's work include Ubiquitin and proteasome pathways (6 papers), Cancer-related gene regulation (4 papers) and Epigenetics and DNA Methylation (3 papers). Huiyin Lan is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Cancer-related gene regulation (4 papers) and Epigenetics and DNA Methylation (3 papers). Huiyin Lan collaborates with scholars based in China, United States and India. Huiyin Lan's co-authors include Jian‐Xin Xu, Yuxin Lin, Hongchuan Jin, Haiqi Lu, Xian Wang, Yi Sun, Zaiming Tang, Yuezhen Wang, Yuxin Lin and Xiaoxin Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and FEBS Letters.

In The Last Decade

Huiyin Lan

18 papers receiving 1.7k citations

Hit Papers

Tumor-associated macrophages in tumor metastasis: biologi... 2019 2026 2021 2023 2019 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huiyin Lan China 11 931 608 529 508 145 18 1.7k
Mahdi Abdoli Shadbad Iran 22 558 0.6× 454 0.7× 339 0.6× 569 1.1× 110 0.8× 60 1.3k
Aki Pui‐Wah Tse Hong Kong 14 764 0.8× 386 0.6× 600 1.1× 358 0.7× 109 0.8× 17 1.4k
Fabien Franco Switzerland 12 659 0.7× 1.1k 1.8× 520 1.0× 738 1.5× 114 0.8× 14 1.9k
Elena Jachetti Italy 18 581 0.6× 680 1.1× 374 0.7× 532 1.0× 99 0.7× 35 1.3k
Matthew L. Arwood United States 8 656 0.7× 736 1.2× 658 1.2× 396 0.8× 77 0.5× 11 1.4k
Ming Lü China 20 812 0.9× 622 1.0× 553 1.0× 449 0.9× 95 0.7× 40 1.7k
Shan Rao China 11 872 0.9× 311 0.5× 668 1.3× 291 0.6× 86 0.6× 19 1.4k
Goran Micevic United States 16 1.0k 1.1× 974 1.6× 588 1.1× 796 1.6× 70 0.5× 32 2.0k
Yueyun Pan China 4 600 0.6× 801 1.3× 260 0.5× 508 1.0× 135 0.9× 5 1.4k

Countries citing papers authored by Huiyin Lan

Since Specialization
Citations

This map shows the geographic impact of Huiyin Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiyin Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiyin Lan more than expected).

Fields of papers citing papers by Huiyin Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiyin Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiyin Lan. The network helps show where Huiyin Lan may publish in the future.

Co-authorship network of co-authors of Huiyin Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Huiyin Lan. A scholar is included among the top collaborators of Huiyin Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiyin Lan. Huiyin Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Yin, Lu, Xiaoming Peng, Huiyin Lan, et al.. (2025). The FBXW7–KMT2 axis in cancer-associated fibroblasts controls tumor growth via an epigenetic-paracrine mechanism. Proceedings of the National Academy of Sciences. 122(13). e2423130122–e2423130122. 4 indexed citations
2.
Chen, Zhiheng, Jin Jiang, Qianping Chen, et al.. (2025). The role of cGAS-STING in remodeling the tumor immune microenvironment induced by radiotherapy. Critical Reviews in Oncology/Hematology. 209. 104658–104658. 4 indexed citations
3.
Lan, Huiyin, et al.. (2024). Mechanisms and emerging strategies for irinotecan-induced diarrhea. European Journal of Pharmacology. 974. 176614–176614. 19 indexed citations
4.
Huang, Cheng-Yi, Huiyin Lan, Quanquan Sun, et al.. (2024). Rifaximin alleviates irinotecan-induced diarrhea in mice model. Annals of Medicine. 56(1). 2429029–2429029. 2 indexed citations
5.
Zhang, Chun‐Dong, Quanquan Sun, Qianping Chen, et al.. (2023). Unraveling Colorectal Cancer and Pan-cancer Immune Heterogeneity and Synthetic Therapy Response Using Cuproptosis and Hypoxia Regulators by Multi-omic Analysis and Experimental Validation. International Journal of Biological Sciences. 19(11). 3526–3543. 8 indexed citations
6.
Lan, Huiyin, et al.. (2022). Comprehensive Analysis of Circular RNA Expression Profiles in Gefitinib-Resistant Lung Adenocarcinoma Patients. Technology in Cancer Research & Treatment. 21. 2213881055–2213881055. 4 indexed citations
7.
Feng, Tao, et al.. (2022). Prevalent distribution and survival outcome of HPV infection in patients with early-stage cervical cancer in Hangzhou, China. BMC Infectious Diseases. 22(1). 941–941. 3 indexed citations
8.
Lin, Yuxin, et al.. (2022). Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review. Frontiers in Oncology. 12. 824308–824308. 7 indexed citations
9.
Lan, Huiyin & Yi Sun. (2021). Tumor Suppressor FBXW7 and Its Regulation of DNA Damage Response and Repair. Frontiers in Cell and Developmental Biology. 9. 751574–751574. 15 indexed citations
10.
Gu, Feiying, Yuxin Lin, Zhun Wang, et al.. (2020). Biological roles of LSD1 beyond its demethylase activity. Cellular and Molecular Life Sciences. 77(17). 3341–3350. 84 indexed citations
12.
Lin, Yuxin, Jian‐Xin Xu, & Huiyin Lan. (2019). Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. Journal of Hematology & Oncology. 12(1). 76–76. 1039 indexed citations breakdown →
13.
Lan, Huiyin, Mingjia Tan, Qiang Zhang, et al.. (2019). LSD1 destabilizes FBXW7 and abrogates FBXW7 functions independent of its demethylase activity. Proceedings of the National Academy of Sciences. 116(25). 12311–12320. 60 indexed citations
14.
Lan, Huiyin & Yi Sun. (2019). FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded. Protein & Cell. 10(12). 861–863. 10 indexed citations
15.
Zhang, Wenfeng, Jie Xu, Fei Yang, et al.. (2017). CyclinG1 Amplification Enhances Aurora Kinase Inhibitor-Induced Polyploid Resistance and Inhibition of Bcl-2 Pathway Reverses the Resistance. Cellular Physiology and Biochemistry. 43(1). 94–107. 11 indexed citations
16.
Lan, Huiyin, Zaiming Tang, Hongchuan Jin, & Yi Sun. (2016). Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells. Scientific Reports. 6(1). 24218–24218. 86 indexed citations
17.
Lan, Huiyin, Haiqi Lu, Xian Wang, & Hongchuan Jin. (2015). MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges. BioMed Research International. 2015. 1–17. 269 indexed citations
18.
Lu, Haiqi, Wei Jin, Jie Sun, et al.. (2014). New tumor suppressor CXXC finger protein 4 inactivates mitogen activated protein kinase signaling. FEBS Letters. 588(18). 3322–3326. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026